BIAFVSGDTC• 28 Days (Normalized)
BIAF vs GDTC (bioAffinity Technologies Inc. vs CytoMed Therapeutics Limited)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BIAF Performance $7.95
+31.84%
bioAffinity Technologies Inc.
Normalized Baseline0.00%
GDTC Performance $0.78
-17.6%
CytoMed Therapeutics Limited
Normalized Baseline0.00%
Alpha Spread Margin BIAF LEADS
+49.44%
BIAF outperforming by 49.44%
BIAFGDTC
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BIAF GDTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | BIAF Price | BIAF Gain (%) | GDTC Price | GDTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $7.95 | +31.84% | $0.78 | -17.60% | +49.44% |
| Sep 10, 2026 | $9.39 | +55.72% | $0.81 | -14.65% | +70.37% |
| Sep 09, 2026 | $10.50 | +74.13% | $0.80 | -16.23% | +90.36% |
| Sep 08, 2026 | $8.93 | +48.09% | $0.87 | -8.32% | +56.41% |
| Sep 04, 2026 | $15.27 | +153.23% | $0.86 | -9.27% | +162.50% |
| Sep 03, 2026 | $12.78 | +111.94% | $0.88 | -7.27% | +119.21% |
| Sep 02, 2026 | $9.75 | +61.69% | $0.88 | -7.27% | +68.96% |
| Sep 01, 2026 | $6.59 | +9.29% | $0.91 | -4.21% | +13.50% |
| Aug 31, 2026 | $4.56 | -24.38% | $0.91 | -4.21% | -20.17% |
| Aug 28, 2026 | $4.87 | -19.24% | $0.92 | -3.06% | -16.18% |
| Aug 27, 2026 | $5.06 | -16.09% | $0.95 | +0.11% | -16.20% |
| Aug 26, 2026 | $5.09 | -15.59% | $1.00 | +5.06% | -20.65% |
| Aug 25, 2026 | $5.19 | -13.93% | $0.94 | -1.48% | -12.45% |
| Aug 24, 2026 | $5.82 | -3.48% | $1.00 | +5.37% | -8.85% |
| Aug 21, 2026 | $6.00 | -0.50% | $1.03 | +8.54% | -9.04% |
Page 1 of 2